Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorometholone versus loteprednol after photorefractive keratectomy
IRCT20131229015975N6Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in myopia and astigmatism comparing Fluorometholone arm with Loteprednol arm (2 arms). Primary endpoints: Best corrected distance visual acuity and Corneal optical density. Started Apr 2016; status: completed.
02
Drugs
fluorometholoneloteprednol etabonate
03
Conditions
myopiaastigmatism
Beyond the preview
Go deeper on IRCT20131229015975N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131229015975N6.